Seroatlas · Human Serome Atlas

TIGAR

Fructose-2,6-bisphosphatase TIGAR

Also known as: C12orf5, TIGAR_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9NQ88
Gene
TIGAR
Ensembl
ENSG00000078237
Chromosome
12
Canonical length
270 aa
Protein class
Enzymes, Metabolic proteins, Predicted intracellular proteins
Subcellular location
Cytosol

OverviewNCBI Gene

This gene is regulated as part of the p53 tumor suppressor pathway and encodes a protein with sequence similarity to the bisphosphate domain of the glycolytic enzyme that degrades fructose-2,6-bisphosphate. The protein functions by blocking glycolysis and directing the pathway into the pentose phosphate shunt. Expression of this protein also protects cells from DNA damaging reactive oxygen species and provides some protection from DNA damage-induced apoptosis. The 12p13.32 region that includes this gene is paralogous to the 11q13.3 region. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

270 residues, UniProt reviewed canonical sequence.

>Q9NQ88|TIGAR
     1  MARFALTVVR HGETRFNKEK IIQGQGVDEP LSETGFKQAA AAGIFLNNVK FTHAFSSDLM
    61  RTKQTMHGIL ERSKFCKDMT VKYDSRLRER KYGVVEGKAL SELRAMAKAA REECPVFTPP
   121  GGETLDQVKM RGIDFFEFLC QLILKEADQK EQFSQGSPSN CLETSLAEIF PLGKNHSSKV
   181  NSDSGIPGLA ASVLVVSHGA YMRSLFDYFL TDLKCSLPAT LSRSELMSVT PNTGMSLFII
   241  NFEEGREVKP TVQCICMNLQ DHLNGLTETR

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TIGAR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
2.9 nTPM

Expression across tissuesHPA

Tissue

  • spinal cord: 2.9 nTPM
  • skeletal muscle: 2.7 nTPM
  • midbrain: 2.5 nTPM
  • pituitary gland: 2.4 nTPM
  • cerebral cortex: 2.2 nTPM
  • hippocampal formation: 2.1 nTPM

Single-cell type

  • renal collecting duct principal cells: 31 nCPM
  • renal collecting duct intercalated cells: 25 nCPM
  • papillary tip epithelial cells: 25 nCPM
  • renal connecting tubule cells: 22 nCPM
  • loop of henle epithelial cells: 18 nCPM
  • proximal tubule cells: 16 nCPM

Immune cell

  • intermediate monocyte: 3.3 nTPM
  • non-classical monocyte: 3.3 nTPM
  • myeloid DC: 1.9 nTPM
  • classical monocyte: 1.7 nTPM
  • plasmacytoid DC: 1.6 nTPM
  • T-reg: 1.4 nTPM

Brain region

  • cerebral cortex: 9.1 nTPM
  • white matter: 7.6 nTPM
  • hippocampal formation: 7.5 nTPM
  • spinal cord: 7.4 nTPM
  • midbrain: 7.3 nTPM
  • pons: 7.3 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.55
gnomAD pLI
0.73
DepMap mean gene effect
0.06
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of TIGAR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TIGAR as an antibody target. Whether an autoantibody or antibody against TIGAR could matter depends on whether native TIGAR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TIGAR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label TIGAR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TIGAR. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...